Sotac Pharmaceuticals Limited — Others, 13-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Sotac Pharmaceuticals Limited has provided a certificate under Regulation 74(5) of SEBI regulations for the quarter ended December 31, 2024. The company confirmed that there were no requests for the dematerialization or rematerialization of shares during the period from October 1, 2024, to December 31, 2024.

This update signals stability in shareholder transactions, indicating that stakeholders are likely holding onto their shares rather than converting them. Investor sentiment might view this as a neutral impact, reflecting confidence in the company's current standing. The absence of trading activity suggests a steady environment, which could pave the way for strategic initiatives in the future.